Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhD
Dr. Peter Gwynne’s research aims to exploit these unique metabolic interactions to design targeted drugs for Lyme disease.
August 29, 2023
Rima Mycynek
Lyme disease expert Peter Gwynne, PhD, presented on “Metabolic Modeling Predicts Unique Drug Targets in the Lyme Disease Pathogen Borrelia burgdorferi” for the Levy CIMAR’s February 2023 Science Seminar. (We chose to post this talk at a later date when Dr. Gwynne & team’s findings were published.) Dr. Gwynne is a research assistant professor at the Tufts University School of Medicine and Director for Translational Research at the Tufts University Lyme Disease Initiative.
Dr. Gwynne is interested in Borrelia burgdorferi, which causes Lyme disease, and the molecular mechanisms the bacterium uses to transition between different hosts such as ticks, mice, and humans. His research aims to exploit these unique metabolic interactions to design targeted drugs for Lyme disease.
Video: Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – Tufts University’s Peter Gwynne, PhD